{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:30:33Z","timestamp":1759483833233},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T00:00:00Z","timestamp":1110499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00228-005-0893-x","type":"journal-article","created":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T16:13:59Z","timestamp":1110471239000},"page":"87-96","source":"Crossref","is-referenced-by-count":13,"title":["Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial"],"prefix":"10.1007","volume":"61","author":[{"given":"Thomas","family":"Elung-Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Heisterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Sonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svend","family":"Strandgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Lise","family":"Kamper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,11]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","volume":"157","author":"Anonymous","year":"1997","unstructured":"Anonymous (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413\u20132446","journal-title":"Arch Intern Med"},{"key":"CR2","first-page":"151","volume":"17","author":"Guidelines","year":"1999","unstructured":"Guidelines subcommittee (1999) World Health Organization\u2014International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 17(2):151\u2013183","journal-title":"J Hypertens"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1093\/ndt\/14.11.2568","volume":"14","author":"H Peters","year":"1999","unstructured":"Peters H, Ritz E (1990) Dosing angiotensin II blockers\u2013beyond blood pressure. Nephrol Dial Transplant 14:2568\u20132570","journal-title":"Nephrol Dial Transplant"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","volume":"349","author":"GISEN","year":"1997","unstructured":"GISEN (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 349:1857\u20131863","journal-title":"Lancet"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.309.6958.833","volume":"309","author":"T Hannedouche","year":"1994","unstructured":"Hannedouche T, Landais P, Goldfarb B et al (1994) Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ 309:833\u2013837","journal-title":"BMJ"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0272-6386(96)90158-4","volume":"27","author":"BU Ihle","year":"1996","unstructured":"Ihle BU, Whitworth JA, Shahinfar S, Cnaan A, Kincaid-Smith PS, Becker GJ (1996) Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial. Am J Kidney Dis 27:489\u2013495","journal-title":"Am J Kidney Dis"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ajh\/5.7.423","volume":"5","author":"AL Kamper","year":"1992","unstructured":"Kamper AL, Strandgaard S, Leyssac PP (1992) Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 5:423\u2013430","journal-title":"Am J Hypertens"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio G, Alberti D, Janin G et al (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group. N Engl J Med 334:939\u2013945","journal-title":"N Engl J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2165\/00003495-199243030-00005","volume":"43","author":"PA Todd","year":"1992","unstructured":"Todd PA, Goa KL (1992) Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension. Drugs 43:346\u2013381","journal-title":"Drugs"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3317\/jraas.2001.038","volume":"4","author":"T Elung-Jensen","year":"2001","unstructured":"Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S, Larsen NE (2001) High serum enalaprilat in chronic renal failure. J Renin Angiotensin Aldosterone Sys 4:240\u2013245","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.0954-6820.1974.tb01053.x","volume":"196","author":"J Kampmann","year":"1974","unstructured":"Kampmann J, Siersbaek-Nielsen K, Kristensen M, Hansen JM (1974) Rapid evaluation of creatinine clearance. Acta Med Scand 196:517\u2013520","journal-title":"Acta Med Scand"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/00365517209084290","volume":"30","author":"J Br\u00f8chner-Mortensen","year":"1972","unstructured":"Br\u00f8chner-Mortensen J (1972) A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271\u2013274","journal-title":"Scand J Clin Lab Invest"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00365518109092020","volume":"41","author":"J Br\u00f8chner-Mortensen","year":"1981","unstructured":"Br\u00f8chner-Mortensen J, Freund LG (1981) Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency. Scand J Clin Lab Invest 41:91\u201397","journal-title":"Scand J Clin Lab Invest"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/clinchem\/30.1.163","volume":"30","author":"P-A Lundberg","year":"1984","unstructured":"Lundberg P-A, Lindstedt G, Andersson T, Braneg\u00e5rd B, Lundquister G, Nystr\u00f6m E (1984) Single-reagent microcentrifugal assay for angiotensin converting enzyme in serum. Clin Chem 30:163","journal-title":"Clin Chem"},{"key":"CR15","unstructured":"Churg J, Cotran RS, Sinniah R, Sakaguchi H, Sobin L Renal disease: classification and atlas of tubulo-interstitial diseases. Igaru-Shoin, Tokyo: 185"},{"key":"CR16","first-page":"419","volume":"5","author":"AA Ajayi","year":"1985","unstructured":"Ajayi AA, Campbell BC, Kelman AW, Howie C, Meredith PA, Reid JL (1985) Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril. Int J Clin Pharmacol Res 5:419\u2013427","journal-title":"Int J Clin Pharmacol Res"},{"key":"CR17","first-page":"142","volume":"32","author":"T Edeki","year":"1994","unstructured":"Edeki T, Johnston A, Li-Kam WE, Turner P (1994) Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing. Int J Clin Pharmacol Ther 32:142\u2013146","journal-title":"Int J Clin Pharmacol Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2125.1982.tb01992.x","volume":"14","author":"J Biollaz","year":"1982","unstructured":"Biollaz J, Schelling JL, Jacot Des CB et al (1982) Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Br J Clin Pharmacol 14:363\u2013368","journal-title":"Br J Clin Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(96)10244-0","volume":"349","author":"EUCLID","year":"1997","unstructured":"EUCLID (1997) Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID study group. Lancet 349:1787\u20131792","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","volume":"330","author":"S Klahr","year":"1994","unstructured":"Klahr S, Levey AS, Beck GJ et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 330:877\u2013884","journal-title":"N Engl J Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0002-9343(99)80226-5","volume":"99","author":"LM Laffel","year":"1995","unstructured":"Laffel LM, McGill JB, Gans DJ (1995) The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 99:497\u2013504","journal-title":"Am J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.285.6343.685","volume":"285","author":"CE Mogensen","year":"1982","unstructured":"Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285:685\u2013688","journal-title":"BMJ"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(83)92462-5","volume":"1","author":"HH Parving","year":"1983","unstructured":"Parving HH, Andersen AR, Smidt UM, Svendsen PA (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175\u20131179","journal-title":"Lancet"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2125.2003.01764.x","volume":"55","author":"T Elung-Jensen","year":"2003","unstructured":"Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S (2003) Blood pressure response to conventional and low-dose enalapril in chronic renal failure. Br J Clin Pharmacol 55:139\u2013146","journal-title":"Br J Clin Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00005344-199601000-00002","volume":"27","author":"AD Hersh","year":"1996","unstructured":"Hersh AD, Kelly JG, Laher MS, Carmody M, Doyle GD (1996) Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function. J Cardiovasc Pharmacol 27:7\u201311","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"CR26","first-page":"A368","volume":"33","author":"LJ Riley Jr","year":"1999","unstructured":"Riley LJ Jr, Fruncillo RJ, Smith R, Vlasses PH, Conner DP, Narins RG, Rocci ML Jr, Mojaverian P, Krishna G, Till A, Ferguson RK (1999) Enalapril maleate in renal failure: relationships between blood pressure response, aldosterone and accumulation of active metabolite. Clin Res 33(2):A368","journal-title":"Clin Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2337\/diacare.23.12.1823","volume":"23","author":"The","year":"2000","unstructured":"The ATLANTIS Study Group (2000) Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care 23:1823\u20131829","journal-title":"Diabetes Care"},{"key":"CR28","first-page":"A0392","volume":"12","author":"PS Kincaid-Smith","year":"2001","unstructured":"Kincaid-Smith PS, Fairley KF, Packham D (2001) Comparison of the effect of 50% increase in angiotensin converting enzyme inhibitor (ACEI) with a combination of candesartan and ACEI on proteinuria and blood pressure in chronic renal disease. J Am Soc Nephrol 12: A0392","journal-title":"J Am Soc Nephrol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0272-6386(99)70181-2","volume":"33","author":"T Keilani","year":"1999","unstructured":"Keilani T, Danesh FR, Schlueter WA, Molteni A, Batlle D (1999) A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium. Am J Kidney Dis 33:450\u2013457","journal-title":"Am J Kidney Dis"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archinte.158.1.26","volume":"158","author":"LC Reardon","year":"1998","unstructured":"Reardon LC, Macpherson DS (1998) Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med 158:26\u201332","journal-title":"Arch Intern Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00365519009089178","volume":"50","author":"AL Kamper","year":"1990","unstructured":"Kamper AL, Nielsen OJ (1990) Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 50:611\u2013618","journal-title":"Scand J Clin Lab Invest"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-005-0893-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0893-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T08:30:02Z","timestamp":1586161802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-005-0893-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,11]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1007\/s00228-005-0893-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,11]]}}}